SQSTM1 and digestive system carcinoma: Recently, aberrant intracellular expression of p62 has been identified in various solid tumors, including hepatocellular, breast, ovarian, prostate, oral, some gastrointestinal carcinomas, and melanoma (Ruan et al., 2017).